Factors Associated With Completion of the Human Papillomavirus Vaccine Series

Neubrand, Tara; Breitkopf, Carmen Radecki; Rupp, Richard; Breitkopf, Daniel M.; Rosenthal, Susan L.

doi:10.1177/0009922809337534

Cited by 66 publications

(64 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These findings are consistent with other studies; Neubrand et al (2009) showed that Hispanics were 60% less likely than whites to complete vaccination. Widdice and colleagues ( 2011) showed that blacks and publicly insured patients were 50% and 24% less likely than whites and privately insured patients, respectively, to complete vaccination.…”

Section: Discussionsupporting

confidence: 93%

Practice of HPV Vaccine and Associated Factors among School Girls in Melaka, Malaysia

Al-Naggar¹,

Bobryshev²,

Al-Jashamy³

et al. 2012

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Objective: The objective of this study is to determine the practice and associated factors of HPV vaccine among school girls in Melaka, Malaysia. Methodology: A total number of 612 secondary school girls participated in this study. The questionnaire consists of 38 questions which included 3 sections. The first section is about sociodemography. The Second section is about knowledge and awareness of HPV vaccines. The third section is about practices with associated barriers of HPV vaccination. Verbal consent was obtained from all participants, and data were analyzed using SPSS 13. Results: A total number of 612 secondary school girl students participated in this study. The mean age was 13.93±SD (1.09); minimum age was 13 years old and maximum was 17 years old. The majority of them was Malay, from rural areas and had a family monthly income of RM 3000 or less (91.8%, 53.1%, 69.6%; respectively). The majority of the parents of the school girls were with secondary education level (56.4%). The majority of the participants did not have a family history of cervical cancer (99.0%). The prevalence of HPV vaccination was 77.9% among school girls in Melaka. The majority of the participants were vaccinated in their schools (77.0%). About 69% knew about cervical cancer and 77.6% had ever heard about HPV vaccine. Regarding the factors that influence the practice of uptake HPV vaccine, they were age, race, income, parents' education, knowledge about cervical cancer, heard about HPV vaccine and place of getting the vaccine (p<0.001). Conclusion: The prevalence of HPV vaccine among school girls is high. Age, race, income, parents' education, knowledge about cervical cancer, heard about HPV vaccine and place of getting the vaccine were the significant factors that influence the practice of uptake HPV vaccine among school girls.

show abstract

Section: Discussionsupporting

confidence: 93%

Practice of HPV Vaccine and Associated Factors among School Girls in Melaka, Malaysia

Al-Naggar¹,

Bobryshev²,

Al-Jashamy³

et al. 2012

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

show abstract

“…7 Female patients who self-identified as black, compared with those who selfidentified as white, were less likely to complete vaccination within 7 and 12 months. This is consistent with previous reports of HPV4 vaccine completion 8,20,36,37 as well as hepatitis B vaccine completion in adolescents. 25,30,38 This disparity is concerning given that the incidence of and mortality from cervical cancer is higher among black women than white women in our community and nationally.…”

Section: Discussionsupporting

confidence: 93%

Adherence to the HPV Vaccine Dosing Intervals and Factors Associated With Completion of 3 Doses

2010

PEDIATRICS

View full text Add to dashboard Cite

WHAT'S KNOWN ON THIS SUBJECT:Vaccination to prevent human papillomavirus infection is safe and effective. Rates of receiving all 3 doses after initiating vaccination range from 42% to 60%, according to early reports from managed health care organizations and the Centers for Disease Control and Prevention. WHAT THIS STUDY ADDS:We determined that few female patients received the second and third human papillomavirus vaccine doses early, and most girls received the second and third doses either late or not at all. Race, health care use, and insurance were associated with completion.abstract OBJECTIVE: The objectives of this study were to determine (1) adherence to the immunization schedule for the human papillomavirus quadrivalent vaccine and (2) factors associated with completion of the 3-dose series. METHODS:This was a retrospective review of health information records from an academic medical center. The sample included all 9-to 26-year-old female patients who initiated vaccination within 2 years after quadrivalent vaccine availability. Multivariable logistic regression models were estimated to determine associations with completion of the 3-dose series within 7 and 12 months. RESULTS:Among the 3297 female patients who initiated vaccination with human papillomavirus quadrivalent vaccine, 67% self-identified as black and 29% self-identified as white. Fewer than 3% of vaccine doses were received earlier than recommended, but Ͼ50% of doses were received late. Completion rates were 14% by 7 months and 28% by 12 months. Independent predictors of completion by 7 months included white versus black race (odds ratio [OR]: 2.04 [95% confidence interval (CI): 1.64 -2.56]; P Ͻ .001), use of contraception that required intramuscular injections every 3 months (OR: 1.53 [95% CI: 1.12-1.95]; P Ͻ .001), and private versus public insurance (OR: 1.31 [95% CI: 1.06 -1.63]; P Ͻ .05). Age and clinic type were not independent predictors of completion. CONCLUSIONS:Adherence to recommended intervals and completion of the vaccine series were low. Lower rates of completion in black patients compared with white patients raises concern that disparities in vaccine completion could exacerbate existing disparities in cervical cancer.

show abstract

“…Therefore, the modeling of beneficial effects from herd immunity is only speculative until vaccine uptake increases. Regarding vaccine compliance, not everyone who initiates the vaccine series completes all 3 doses or completes all doses in the recommended 6-month time frame, 55 and it is presently unknown how noncompliance affects vaccine efficacy and duration of protection.…”

Section: ■■ Discussion and Limitationsmentioning

confidence: 99%

Prophylaxis of Cervical Cancer and Related Cervical Disease: A Review of the Cost-Effectiveness of Vaccination Against Oncogenic HPV Types

Armstrong¹

2010

JMCP

131

100

View full text Add to dashboard Cite

BACKGROUND: Vaccines have demonstrated cost-effectiveness in managed care through the prevention of disease. As new vaccines for previously untargeted conditions are developed, pharmacoeconomic modeling is becoming even more critical for the quantification of value in the health care industry. Two recently developed vaccines aimed at prevention of infection from human papillomavirus (HPV) types 16 and 18 have proven to be highly efficacious. HPV 16 and 18 are the 2 most common oncogenic strains of HPV and are responsible for 70% of cervical cancer cases worldwide. Persistent infection with an oncogenic HPV type is a known cause of cervical cancer. Therefore, prevention of cervical cancer via HPV vaccination may have a significant financial impact.

show abstract

Factors Associated With Completion of the Human Papillomavirus Vaccine Series

Cited by 66 publications

References 11 publications

Practice of HPV Vaccine and Associated Factors among School Girls in Melaka, Malaysia

Practice of HPV Vaccine and Associated Factors among School Girls in Melaka, Malaysia

Adherence to the HPV Vaccine Dosing Intervals and Factors Associated With Completion of 3 Doses

Prophylaxis of Cervical Cancer and Related Cervical Disease: A Review of the Cost-Effectiveness of Vaccination Against Oncogenic HPV Types

Contact Info

Product

Resources

About